These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Pharmacotherapy of central oculomotor disorders].
    Author: Kalla R, Spiegel R, Wagner J, Rettinger N, Jahn K, Strupp M.
    Journal: Nervenarzt; 2008 Dec; 79(12):1377-8, 1380-2, 1384-5. PubMed ID: 18633586.
    Abstract:
    Nystagmus causes blurred vision due to oscillopsia, as well as impaired balance. Depending on etiology, additional cerebellar and brain stem signs may occur. We present the current pharmacotherapy of the most common forms of central nystagmus: downbeat nystagmus (DBN), upbeat nystagmus (UBN), acquired pendular nystagmus (APN), and congenital nystagmus (CGN). Recommended medical therapies are aminopyridines (4-AP) for DBN and UBN, gabapentin and memantine for CGN and APN, and baclofen for periodic alternating nystagmus (PAN).
    [Abstract] [Full Text] [Related] [New Search]